Summary: A collaborative study finds that strong overall brain health can protect memory and thinking abilities from the early, damaging effects of Alzheimer’s disease.
Researchers investigated why some older adults remain cognitively sharp despite showing early biological signs of Alzheimer’s. Their results indicate that preserved brain structure and overall brain integrity act as a significant buffer against early Alzheimer’s-related changes. The findings point to an important preventive window where lifestyle and public-health strategies could preserve cognition before clinical decline or dementia appears.
Key Facts
- The pathological paradox: Some older adults show early Alzheimer’s-related brain changes but have no noticeable memory loss or cognitive impairment.
- Brain health as a shield: The study’s primary result suggests that maintaining strong overall brain health reduces the negative impact of early Alzheimer’s-related biology on cognitive performance.
- Socioeconomic influence: Initial evidence indicates that higher socioeconomic status—assessed by education, income, savings and financial security—may lessen the effect of early Alzheimer’s pathology on memory, though further research is needed.
- The clinical cohort: The analysis used data from more than 600 independently living older adults in the United States, ages 65–80, combining blood biomarkers, MRI measures and comprehensive cognitive testing.
Source: Murdoch University
A healthy brain may help protect thinking and memory skills from early Alzheimer’s disease, a new study reports.
Dementia is the leading cause of death in Australia, and Alzheimer’s disease accounts for the majority of dementia cases. Alzheimer’s is a progressive condition characterized by gradual decline in memory and other cognitive abilities. Yet some people remain cognitively intact even when their brains show early Alzheimer’s-related pathology.
The study, titled Cognitive and Brain Reserve as Modifiers of Early Alzheimer Disease–Related Cognitive Vulnerability, was conducted by researchers at Murdoch University in collaboration with AdventHealth. It examined why some older adults preserve cognitive function despite biological signs of Alzheimer’s disease.
“We wanted to understand why some brains are more resilient than others, and whether factors such as education, socioeconomic status and the structural health of the brain make a difference,” said lead author Dr. Kelsey Sewell from Murdoch University’s School of Allied Health.
The research team analyzed baseline data from a multisite trial, including over 600 cognitively unimpaired, physically inactive, community-dwelling adults aged 65 to 80. Participants underwent blood tests and MRI scans to measure early Alzheimer’s-related biomarkers and overall brain integrity. The study also evaluated life-course and social factors—years of education, income, savings and financial security—alongside a cognitive test battery measuring memory, attention, processing speed, working memory and executive function.
“Our main finding was that better overall brain health appears to reduce the impact of early Alzheimer’s-related changes on cognition,” Dr. Sewell said. “We also found preliminary evidence that higher socioeconomic status may buffer memory performance against early pathology, though that result requires further confirmation.”
Dr. Sewell emphasized practical takeaways for the public: maintain brain health through regular physical activity, a balanced nutrient-rich diet, healthy sleep patterns and ongoing cognitive challenges—because it’s never too early or too late to support brain resilience.
She added that the results point to the need for coordinated efforts across research, policy and industry to design environments that encourage healthier choices and support brain health at the population level.
Data collection for the study was led by researchers at AdventHealth in Orlando, Florida.
Key Questions Answered:
A: This can be explained by brain and cognitive reserve. People who maintain good brain structure and develop rich neural networks through an active, stimulating lifestyle can reroute neural signals around early damage. That compensatory capacity helps keep memory and thinking skills intact despite underlying pathology.
A: Core strategies include regular physical exercise, a nutritious diet, consistent sleep hygiene, and routinely introducing new and demanding cognitive activities. These habits support brain structure and promote cognitive reserve across the lifespan.
A: Higher socioeconomic status often correlates with better lifelong access to healthcare, lower chronic stress, higher education and more opportunities for cognitive enrichment. Together, these factors can contribute to a stronger neurological buffer against disease-related tissue changes.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by staff.
About this Alzheimer’s disease research news
Author: Ezra Kaye
Source: Murdoch University
Contact: Ezra Kaye – Murdoch University
Image: Image credited to Neuroscience News
Original Research: Open access. “Cognitive and Brain Reserve as Modifiers of Early Alzheimer Disease–Related Cognitive Vulnerability” by Kelsey R. Sewell et al., published in Neurology. DOI: 10.1212/WNL.0000000000214833
Abstract
Cognitive and Brain Reserve as Modifiers of Early Alzheimer Disease–Related Cognitive Vulnerability
Background and Objectives
Cognitive reserve describes the ability to maintain cognitive function despite the presence of Alzheimer’s disease (AD) pathology. While research supports this concept, the field lacks standardized ways to quantify both cognitive and brain reserve. This study tested whether proxy measures of reserve—years of education and socioeconomic status for cognitive reserve, and brain-predicted age difference plus a volumetric Alzheimer’s signature for brain reserve—modify the link between AD pathology and cognitive performance. The hypothesis was that stronger structural brain integrity, higher education and higher socioeconomic status would weaken the association between greater AD pathology and poorer cognition.
Methods
This cross-sectional analysis used baseline data from a multisite randomized clinical trial conducted at three U.S. universities. Participants were cognitively unimpaired, physically inactive, community-dwelling older adults. AD pathology was measured primarily by plasma phosphorylated tau (p-tau217) and secondarily by PET amyloid (Aβ) in a subset. Cognitive outcomes were assessed with a comprehensive test battery. Socioeconomic status was estimated via the MacArthur Socioeconomic Status Index, and MRI provided measures of brain-predicted age difference (brain-PAD) and a volumetric AD signature. Linear regression models with interaction terms evaluated moderation effects.
Results
A total of 621 participants (mean age 69.9 ± 3.8 years; 71% female) contributed data to the primary analyses; 355 had PET Centiloid data. Brain-PAD moderated the relationship between p-tau217 and several cognitive domains: episodic memory, processing speed, working memory and executive/attentional control. In each case, the negative association between AD pathology and cognitive performance was weakest among individuals whose brains appeared younger on MRI. A latent socioeconomic status score also moderated the link between p-tau217 and episodic memory in initial analyses, but this finding did not remain significant after correcting for multiple comparisons. Neither years of education nor the volumetric AD signature significantly moderated the pathology–cognition associations.
Discussion
These results support the idea that greater brain and cognitive reserve can buffer the cognitive effects of early Alzheimer’s pathology. Interventions and lifestyle strategies that strengthen brain structure and cognitive reserve—such as physical activity, cognitive engagement and improved cardiovascular health—may help build resilience to emerging AD pathology. Longitudinal studies will be needed to confirm whether improving these reserve measures can delay or reduce clinical cognitive decline.